Novel variants and clinical symptoms in four new ALG3-CDG patients, review of the literature, and identification of AAGRP-ALG3 as a novel ALG3 variant with alanine and glycine-rich N-terminus.
Animals
COS Cells
Cells, Cultured
Child, Preschool
Chlorocebus aethiops
Congenital Disorders of Glycosylation
/ genetics
Female
Humans
Infant
Male
Mannosyltransferases
/ genetics
Mutation
Open Reading Frames
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase
/ deficiency
Polymorphism, Single Nucleotide
AAGRP
ALG3
CDG-I
congenital disorders of glycosylation
hybrid protein
mannosyltransferase
Journal
Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
22
01
2019
revised:
03
04
2019
accepted:
09
04
2019
pubmed:
9
5
2019
medline:
18
3
2020
entrez:
9
5
2019
Statut:
ppublish
Résumé
ALG3-CDG is one of the very rare types of congenital disorder of glycosylation (CDG) caused by variants in the ER-mannosyltransferase ALG3. Here, we summarize the clinical, biochemical, and genetic data of four new ALG3-CDG patients, who were identified by a type I pattern of serum transferrin and the accumulation of Man
Substances chimiques
ALG3 protein, human
EC 2.4.1.-
Mannosyltransferases
EC 2.4.1.-
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase
EC 3.5.1.52
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
938-951Subventions
Organisme : Fondation Maladies Rares
ID : High throughput sequencing and Rare Diseases Proje
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : FOR2509: TH1461/7-1
Pays : International
Organisme : European Union's Horizon 2020 research and innovation program
ID : ERA-NET Cofundation N° 643578 - EURO-CDG 2/ BMB
Pays : International
Informations de copyright
© 2019 Wiley Periodicals, Inc.